Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis

Chris Stockmann; Catherine M.t. Sherwin; Krow Ampofo; Michael G. Spigarelli

doi:10.1177/1753465813508445

Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis

Chris Stockmann, Catherine M.t. Sherwin, Krow Ampofo, Michael G. Spigarelli

Wright State University

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	13-21
Number of pages	9
Journal	Therapeutic Advances in Respiratory Disease
Volume	8
Issue number	1
DOIs	https://doi.org/10.1177/1753465813508445
State	Published - Feb 1 2014

ASJC Scopus Subject Areas

Pulmonary and Respiratory Medicine
Pharmacology (medical)

Keywords

acute pulmonary exacerbations
aerosolized antibiotics
antibacterial
antibiotic
antipseudomonal antimicrobial
fluoroquinolones
MP-376

Disciplines

Medical Specialties
Medicine and Health Sciences
Pediatrics

Access to Document

10.1177/1753465813508445

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564390/

Cite this

@article{4c3a2d17e15e425889789710458451cd,

title = "Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis",

keywords = "acute pulmonary exacerbations, aerosolized antibiotics, antibacterial, antibiotic, antipseudomonal antimicrobial, fluoroquinolones, MP-376",

author = "Chris Stockmann and Sherwin, {Catherine M.t.} and Krow Ampofo and Spigarelli, {Michael G.}",

year = "2014",

month = feb,

day = "1",

doi = "10.1177/1753465813508445",

language = "English",

volume = "8",

pages = "13--21",

journal = "Therapeutic Advances in Respiratory Disease",

issn = "1753-4658",

number = "1",

}

TY - JOUR

T1 - Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis

AU - Stockmann, Chris

AU - Sherwin, Catherine M.t.

AU - Ampofo, Krow

AU - Spigarelli, Michael G.

PY - 2014/2/1

Y1 - 2014/2/1

KW - acute pulmonary exacerbations

KW - aerosolized antibiotics

KW - antibacterial

KW - antibiotic

KW - antipseudomonal antimicrobial

KW - fluoroquinolones

KW - MP-376

UR - http://www.scopus.com/inward/record.url?scp=84893085519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893085519&partnerID=8YFLogxK

UR - https://corescholar.libraries.wright.edu/pediatrics/276

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564390/

U2 - 10.1177/1753465813508445

DO - 10.1177/1753465813508445

M3 - Review article

C2 - 24334337

AN - SCOPUS:84893085519

SN - 1753-4658

VL - 8

SP - 13

EP - 21

JO - Therapeutic Advances in Respiratory Disease

JF - Therapeutic Advances in Respiratory Disease

IS - 1

ER -

Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis

ASJC Scopus Subject Areas

Keywords

Disciplines

Access to Document

Other files and links

Cite this